https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-11-26 / J Transl Med 2019 11;17(1):391
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-11-26 / J Transl Med 2019 11;17(1):3912019-11-26 00:00:002020-08-26 13:58:47A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-11-25 / J Immunol Res 2019;2019:9631515
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-11-25 / J Immunol Res 2019;2019:96315152019-11-25 00:00:002019-11-25 00:00:00Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-01 / Jpn. J. Clin. Oncol. 2019 Sep;49(9):832-838
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-01 / Jpn. J. Clin. Oncol. 2019 Sep;49(9):832-8382019-09-01 00:00:002020-08-26 14:25:47Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e17032)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e17032)2019-05-31 00:00:002019-05-31 00:00:00A phase I trial evaluating the safety and efficacy of weekly paclitaxel or cisplatin with electro-hyperthermia in patients with recurrent or persistent epithelial ovarian, fallopian tubal or primary peritoneal carcinoma (KGOG 3030).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-11 / Front Immunol 2019;10:766
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-11 / Front Immunol 2019;10:7662019-04-11 00:00:002019-07-01 08:10:01Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-05 / Surg. Oncol. Clin. N. Am. 2019 Jul;28(3):447-464
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-05 / Surg. Oncol. Clin. N. Am. 2019 Jul;28(3):447-4642019-04-05 00:00:002019-04-05 00:00:00Immunotherapy in Ovarian Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-03-01 / J Clin Oncol 37, 2019 (suppl 8; abstr TPS10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-03-01 / J Clin Oncol 37, 2019 (suppl 8; abstr TPS10)2019-03-01 00:00:002020-05-06 15:08:24Randomized phase II trial of patient-specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-14 / Int J Hyperthermia 2019;36(1):9-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-14 / Int J Hyperthermia 2019;36(1):9-202018-11-14 00:00:002019-03-27 10:49:05Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-1638
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-16382018-09-11 00:00:002018-09-11 00:00:00Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-08-23 / Ann Res Hosp 2018 Aug;2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-08-23 / Ann Res Hosp 2018 Aug;22018-08-23 00:00:002020-02-05 10:32:52Further clinical advancement of dendritic cell vaccination against ovarian cancer
